Norwest Venture Partners — 2018 Investments
4 investments dated 2018 · listed companies and verified rows first · show all
Mirum Pharmaceuticals is a biopharmaceutical company that develops and delivers therapies for people living with rare diseases.
BiotechHealthtechSan Diego, US
Chris Peetz(Co-founder & Chief Executive Officer)inMichael Grey(Director)Timothy Walbert(Director)Saira Ramasastry(Director)Lon Cardon(Director)Laurent Fischer(Director)
Board seatTiba Aynechi· per SEC Form D · $10M raise · filed Dec 2020
Co-investorsChiesi VenturesFrazier Life SciencesNew Enterprise Associates (NEA)RiverVest Venture Partners
San Francisco, US
Susan Kuo(Executive Officer)Eran Friedman(Executive Officer, Director)Gadi Eliashiv(Executive Officer, Director)Nichael Oiknine(Executive Officer)
BoardChristopher Capps(Director)Jay Eum(Director)
Board seatScott Beechuk· per SEC Form D · $30M raise · filed Sep 2018
Co-investorsGeneral Catalyst
Wyze designs affordable smart home hardware including security cameras, video doorbells, smart locks, and health devices, along with a companion app that connects them.
ConsumerHardwareIoTKirkland, US
Yun Zhang(Executive Officer, Director)
BoardAdam Lin(Director)
Board seatParker Barrile· per SEC Form D
Co-investorsAmerican Family VenturesAmino CapitalKensington Capital Partners LimitedMarcy Venture Partners
Shape Security (now part of F5) provides bot defense that uses real-time behavioral analysis and platform-wide telemetry to distinguish humans, trusted AI agents, and malicious automation across web apps, mobile apps, and APIs.
AI & Machine LearningCloud ComputingCybersecurityEnterprise SoftwareMenlo Park, US
Tamara MacDuff(Executive Officer)Gaurav Garg(Director)Derek Smith(Executive Officer, Director)Justin Call(Executive Officer)Ray Rothrock(Director)Ted Schlein(Director)
Co-investorsAllegisCyber CapitalBaseline VenturesC5 CapitalEPIC VENTURESJetBlue VenturesKleiner Perkins+6 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.